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Introduction
Mesenchymal stem cells (MSCs) have been defined as 
multipotent cells that adhere to tissue culture polystyrene 
(TCP) and present a characteristic panel of surface mark-
ers, including CD73, CD90 and CD105.1,2 However, the 
majority of early phenotyping studies have been most fre-
quently conducted using human or murine MSCs and, as 
such, are not necessarily translatable for the identification 
of MSCs derived from other species. Indeed, variations 
between cell surface markers have been consistently 
observed between MSCs isolated from humans and non-
humans, such as rats.1,3,4 Due to the frequent use of rat 
MSCs for tissue engineering research,5–7 publications that 
identify effective selection and culture conditions for rat 
Isolation of adipose and bone marrow 
mesenchymal stem cells using CD29 and 
CD90 modifies their capacity for osteogenic 
and adipogenic differentiation
Owen G Davies1,2, Paul R Cooper1, Richard M Shelton1,  
Anthony J Smith1 and Ben A Scheven1
Abstract
Mesenchymal stem cells isolated from rats are frequently used for tissue engineering research. However, considerable 
differences have been identified between rat mesenchymal stem cells and those derived from humans, and no defined 
panel of markers currently exists for the isolation of these cells. The aim of this study was to examine the effects of cell 
sorting for CD29+/CD90+ cells from rat adipose and bone marrow tissues on their differentiation and expression of stem 
cell–associated genes. Flow cytometry showed 66% and 78% CD29+/CD90+ positivity within passage 1 of adipose and bone 
marrow cultures, respectively. CD29+/CD90+ cells showed a reduction in both osteogenic and adipogenic differentiation 
when compared with unsorted cells, as determined by alizarin red and Oil Red-O staining, respectively. These findings 
could not entirely be explained by fluorescence-activated cell sorting–induced cell injury as sort recovery was only modestly 
affected in adipose-derived cells. Maintaining cells in fluorescence-activated cell sorting buffer did not affect adipose-derived 
cell viability, but a significant (p < 0.05) reduction was found in bone marrow–derived cell viability. Additionally, CD29+/
CD90+ selection was associated with a significant decrease in the expression of Lin28, Sox2, Nanog and CD73 in adipose-
derived cell cultures, whereas differences in stem cell–associated gene expression were not observed in sorted bone 
marrow–derived cell cultures. In summary, this study demonstrated that fluorescence-activated cell sorting had differential 
effects on adipose-derived cells and bone marrow–derived cells, and both CD29+/CD90+ cells displayed a significantly 
reduced capacity for osteogenic/adipogenic differentiation. In conclusion, we identify that maintaining heterogeneity within 
the mesenchymal stem cell population may be important for optimal differentiation.
Keywords
Stem cell, adipose, bone marrow, flow cytometry, osteogenic, adipogenic, CD29, CD90, rat
Received: 23 March 2015; accepted: 29 May 2015
1School of Dentistry, University of Birmingham, Birmingham, UK
2Wolfson School of Mechanical and Manufacturing Engineering, 
Loughborough University, Loughborough, UK
Corresponding author:
Owen G Davies, Wolfson School of Mechanical and Manufacturing 
Engineering, Loughborough University, Ashby Road, Loughborough 
LE11 3TU, UK. 
Email: owendavies777@outlook.com
592356 TEJ0010.1177/2041731415592356Journal of Tissue EngineeringDavies et al.
research-article2015
Original Article
 at UNIV OF BIRMINGHAM on July 10, 2015tej.sagepub.comDownloaded from 
2 Journal of Tissue Engineering 
MSCs may be of considerable benefit for tissue engineer-
ing applications.
Notwithstanding the specificity of MSC markers, it has 
been argued that MSCs should be purified/sorted if they 
are to be used for tissue engineering applications, since the 
presence of a heterogeneous mixture of cell types may 
compromise the proliferation and/or differentiation poten-
tial of stem/progenitor cells and limit their potential for 
regenerative applications.8–10 Additionally, since the MSC 
population is inherently heterogeneous, containing cells 
with different proliferation and differentiation capaci-
ties,11–13 studies examining the effects of cell selection cri-
teria on multi-differentiation potential will be of significant 
value for the development of targeted regenerative thera-
pies. Unfortunately, the commercial availability of anti-
bodies raised against rats is limited when compared with 
those raised against humans and mice, limiting the breadth 
of marker profiling studies in this species. However, 
throughout the literature, the combined expression of 
CD29 and CD90 is one of the most consistent identifying 
phenotypic features among MSCs, irrespective of species 
variations.3,14,15 Furthermore, a recent study has indicated 
that CD29+/CD90+ expression is likely conserved among 
stem cells isolated from adipose tissue irrespective of har-
vesting site and age, further making this an appealing pop-
ulation for tissue engineering research.16 Therefore, 
characterisation of CD29+/CD90+ cells derived from major 
MSC stores, such as adipose and bone marrow tissues, is 
of importance to identify their potential suitability as a 
source of stem cells for pre-clinical use.
It must be highlighted that no single unique marker 
exists for the identification of MSCs, and that when used 
independently, the presence of CD29 or CD90 cannot 
effectively distinguish MSCs from other resident cells pre-
sent within the stem cell niche, such as endothelial cells, 
fibroblasts, immunocompetent cells and adipocytes.17,18 
CD90, also known as thymocyte antigen 1 (Thy-1), repre-
sents a 25- to 37-kDa glycosylphosphatidylinositol (GPI)-
linked membrane protein commonly associated with 
osteoprogenitor cells.19 CD29 (integrin beta-1) is frequently 
used, in combination with other cluster of differentiation 
(CD) markers such as CD90, for the identification of MSCs 
and has been shown to be expressed by adipocyte progeni-
tors.20 When used in combination, previous studies have 
shown that CD29+/CD90+ cells isolated from rats have 
demonstrated the capacity for osteogenic and adipogenic 
differentiation.21,22 However, to our knowledge, none of 
these studies have examined whether enriching for a 
CD29+/CD90+ population was able to enhance the differen-
tiation capacity of these cells when compared with TCP-
adherent controls. Therefore, despite some promising 
initial studies, the benefits of selecting CD29+/CD90+ cells 
for tissue engineering applications remain largely unknown.
In this study, we examined the potential of CD29+/
CD90+ cell selection for the isolation of MSC-like cells 
that can be used for tissue engineering applications. These 
cells were compared with unsorted TCP-adherent cells to 
identify whether CD29+/CD90+ enrichment enhanced 
MSC-associated characteristics, such as osteogenic and 
adipogenic differentiation. In these experiments, all cells 
were first expanded on TCP to maximise cell number and 
provide an initial means of MSC selection, as was first 
identified by Friedenstein et al.23 during his initial pioneer-
ing work with bone marrow stem cells.24,25
Materials and methods
Cell isolation and culture
Six-week-old male Wistar Han rats (weight: ~120 g) were 
sacrificed by cervical dislocation (Aston University, 
Pharmaceutical Sciences Animal House, Birmingham, 
UK; ethical approval reference: BCHDent286.1471.TB). 
Adipose tissue was collected from inguinal fat pads and 
bone marrow from femora. Adipose-derived cells (ADCs) 
were isolated by mincing inguinal adipose tissue into 
~1 mm3 pieces, which were incubated with 0.01% type-I 
collagenase (Sigma, UK) for 30 min at 37°C in a rotary 
incubator (SI20H; Stuart Scientific, UK) and centrifuged 
at 1000g for 5 min to pellet the stromal vascular fraction 
(SVF).26,27 Bone marrow–derived cells (BMDCs) were 
flushed from rodent femora by inserting a 22-gauge needle 
attached to a 20-mL syringe containing growth medium 
(alpha-modified minimum essential medium (α-MEM), 
with 10% foetal bovine serum (FBS) and 1% penicillin/
streptomycin; Sigma) into the femoral cavity. Bone mar-
row was flushed and collected in a 50-mL Falcon® tube 
and centrifuged at 900g for 5 min to pellet the BMDCs.28 
ADCs and BMDCs were re-suspended and cultured in 
growth medium until approximately 80% confluent.
Cell viability analysis
To study the effects of maintaining cells in fluorescence-
activated cell sorting (FACS) buffer during blocking, anti-
body labelling and sorting stages, cell viability was 
analysed at 30-min intervals over a total period of 270 min. 
Passage 1 ADCs and BMDCs were cultured until ~80% 
confluent. Cells were then detached using 0.25% trypsin 
(2.5 g/L of trypsin in 0.38 g/L of ethylenediaminetet-
raacetic acid (EDTA)) for 5 min at 37°C (Gibco, UK). 
Following detachment, the cells were centrifuged 
(Eppendorf 5804R; Eppendorf, UK) at 900g for 5 min, 
neutralised with growth medium and the resulting suspen-
sions transferred to 15 mL Falcon tubes. Cell suspensions 
were incubated in FACS buffer (sterile phosphate-buffered 
saline (PBS) + 1% FBS) and maintained at 4°C under con-
stant agitation using an orbital shaker to prevent sedimen-
tation. The number of viable cells was determined every 
30 min by adding 0.4% (w/v) Trypan blue solution 
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(Sigma–Aldrich, UK) to an equal volume of cell suspen-
sion and manually counting the cells using a modified 
Neubauer haemocytometer (Hawksley, UK).
FACS
Passage 1 ADCs and BMDCs were detached with 0.2% 
(w/v) EDTA (Gibco) at 37°C for approximately 5 min and 
centrifuged at 400g (Eppendorf 5804R; Eppendorf) for 
5 min. The supernatant was discarded and 1 µg/mL of anti-
rat Fc block (BD Pharmingen, UK) in sterile PBS was 
added to block non-specific binding sites. Cells were 
washed using sterile PBS, centrifuged at 400g for 5 min 
and the pellet re-suspended in sterile FACS buffer (PBS, 
1% FBS) containing allophycocyanin (APC)-conjugated 
CD29 antibody (eBiosciences, 17-0291, UK) and fluores-
cein isothiocyanate (FITC)-conjugated CD90 antibody 
(eBiosciences, 11-0900, UK) for 30 min. FACS buffer was 
maintained at room temperature. Unsorted cells (i.e. not 
processed through the FACS instrument) and unlabelled 
cells (i.e. not exposed to primary antibody, but processed 
through the FACS instrument) were used as controls. For 
cell selection, a FACSAria II instrument (BD Biosciences, 
Illinois, USA) was equipped with an 85-µm nozzle, and 
cells were sorted at a low sort rate using a pressure of 
45 lbf/in2 (3.1 bar). Cells were acquired and gated using 
forward scatter (FSC) and side scatter (SSC) parameters to 
exclude cell debris and aggregates. Propidium iodide (PI) 
staining (eBiosciences, 00-6990-50, UK) was used to label 
non-viable cells. These cells were excluded prior to analy-
sis. CD29+/CD90+ cells were recovered in growth medium 
containing 10% FBS to maximise viability. Cells were 
rested for a period of approximately 15 min after being 
sorted. All data were analysed using FlowJo software 
(TreeStar, USA).
Sort recovery was measured immediately following 
FACS using the Trypan blue exclusion assay, as previously 
described (section ‘Cell viability analysis’).
Differentiation assays
To assess osteogenic and adipogenic differentiation, 
FACS-recovered cells were seeded at 1 × 105 cells per well 
in 35 mm2 culture dishes (Sarstedt, UK) containing growth 
medium for 24 h. Following expansion, growth medium 
was aspirated and replaced with differentiation medium as 
follows.
Passage 1 CD29+/CD90+, unlabelled (i.e. cells that had 
not been exposed to primary antibody but processed 
through the FACS instrument) and unsorted ADCs and 
BMDCs were cultured in osteogenic medium (50 µg/mL 
ascorbic acid (Sigma), 10 mM β-glycerophosphate (Sigma) 
and 10−9 M dexamethasone (Sigma)) for a period of 
21 days.29,30 Cultures were fixed with 10% (w/v) formalde-
hyde for 20 min (VWR, UK) and stained using 40 mM 
alizarin red (AR), adjusted to pH 4.2 using ammonium 
hydroxide, for 20 min at room temperature under constant 
agitation (Sigma).31 Unbound stain was removed with suc-
cessive washes in PBS. Images of stained cultures were 
captured using a Nikon TE-DH100W (Nikon, UK) camera 
attached to a Nikon Eclipse TE300 microscope (Nikon). 
To quantify the amount of calcium present in each culture, 
the bound AR stain was eluted using 10% (v/v) acetic acid 
and quantified using a spectrophotometer at a wavelength 
of 405 nm (ultraviolet (UV)/visible spectrometer; Philips, 
UK).
To examine adipogenic differentiation, ADCs and 
BMDCs were cultured in adipogenic medium (0.5 mM 
1-methyl-3-isobutylxanthine (Sigma), 60 µM indometha-
cin (Sigma) and 0.5 µM hydrocortisone (Sigma)) for a 
period of 21 days.32 Following differentiation, adipogenic 
medium was aspirated and the cultures fixed with 10% 
(w/v) formaldehyde for a period of 20 min (VWR). After 
fixation, each culture was stained with 0.25% (w/v) Oil 
Red-O (ORO; VWR) dissolved in dH2O (VWR) for 40 min 
at room temperature under constant agitation. Cultures 
were then washed twice with PBS to remove unbound 
ORO. Bound ORO dye was eluted through the addition of 
200 µL of 60% (v/v) propan-2-ol (VWR). Cultures were 
incubated at room temperature for 20 min with constant 
agitation. A total of 60 µL of the eluate was transferred to 
an opaque-walled 96-well assay plate (Corning, UK) and 
the absorbance measured at 500 nm using an ELx800 
plate-reader (BioTek, UK) and normalised according to 
cell number, which was calculated using Trypan blue cell 
counts (section ‘Cell viability analysis’).
Semi-quantitative reverse-transcription 
polymerase chain reaction
RNA was isolated from passage 1 CD29+/CD90+ cells 
directly after FACS, as well as from unsorted controls 
using the Qiagen RNeasy Mini Kit, following the manu-
facturer’s instructions (Qiagen, UK). RNA was reverse 
transcribed into complementary DNA (cDNA) using the 
Qiagen Omniscript RT Kit according to the manufacturer’s 
instructions (Qiagen). A REDTaq mastermix was pro-
duced, comprising 12.5 µL of REDTaq ready mix (Sigma–
Aldrich), 12.5 µL of molecular grade water (BDH 
Laboratory Supplies, UK), 1 µL of 1 µM forward primer 
(Invitrogen, UK) and 1 µL of 1 µM reverse primer 
(Invitrogen). A 6-µL PCR MasterMix was transferred to 
individual 0.2 mL PCR tubes (Appleton Woods, UK) to 
which 50–100 ng of cDNA was added. All components 
were mixed thoroughly using a vortex mixer and trans-
ferred to a GeneAmp 2700 PCR Thermocycler (Applied 
Biosystems, UK). Amplification parameters were opti-
mised for each gene (see Table 1). Expression of genes 
associated with a stem cell phenotype (Table 1) was quan-
tified following amplification by analysing the PCR 
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products on a 1.5% (w/v) agarose gel containing 0.01% 
ethidium bromide (Invitrogen). Gels were then transferred 
to a G:BOX gel documentation and analysis unit (Syngene, 
UK) where the presence of amplified products was 
detected under UV illumination. The housekeeping gene 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
was used to normalise gene expression. All primers were 
manufactured commercially (Invitrogen), and details of 
DNA sequences and gene product sizes are provided in 
Table 1.
Statistical analysis
All data were analysed using SPSS 10.0 for Windows 
(SPSS Inc., USA). Statistical analyses were performed 
using Student’s t-test or a one-way analysis of variance 
(ANOVA) followed by the Bonferroni post hoc test. 
p < 0.05 was considered to indicate statistical significance.
Results
Flow cytometry for a CD29+/CD90+ cell 
population
The total percentage of CD29+, CD90+ and CD29+/CD90+ 
cells within the whole population of adipose and bone 
marrow tissues was analysed using FACS (Figure 1). 
Freshly isolated (P0) ADC cultures contained significantly 
(p < 0.05) higher numbers of CD29+, CD90+ and CD29+/
Table 1. Details of primer sequences, product sizes, annealing temperatures, cycle numbers used, and NCBI gene accession numbers.
Gene Sequence Product size 
(bp)
Annealing 
temperature (°C)
Cycle 
number
Accession 
number
Normalisation
 GAPDH F-CCCATCACCATCTTCCAGGAGC; 473 60.5 21 NM_017008
R-CCAGTGAGCTTCCCGTTCAGC
Pluripotent markers
 Nanog F-TATCGTTTTGAGGGGTGAGG; 356 60.5 31 NM_001100781
R-CAGCTGGCACTGGTTTATCA
 Lin28 F-TTTCTTGTTTCCCCCAAATG; 630 60.5 30 NM_001109269
R-AGAGGGGCTGGTTGTAAGGT
 Sox2 F-ATACAAGGGAATTGGGAGGG; 414 60.5 29 NM_001109181
R-AAACCCAGCAAGAACCCTTT
Multipotent markers
 CD29 F-AATGGAGTGAATGGGACAGG; 2397 60.5 25 NM_017022.2
R-TCTGTGAAGCCCAGAGGTTT
 CD73 F-GGACTGATTGATCCCCTCCT; 401 60.5 25 NM_002526
R-TTGTCCCTGGATTTGAGAGG
 CD90 F-AGCTCTTTGATCTGCCGTGT; 486 60.5 26 NM_012673
R-CTGCAGGCAATCCAATTTTT
 CD105 F-TTCAGCTTTCTCCTCCGTGT; 325 60.5 28 NM_001010968
R-TGTGGTTGGTACTGCTGCTC
GAPDH: glyceraldehyde 3-phosphate dehydrogenase.
Figure 1. Proportion of CD29+, CD90+ and CD29+/CD90+ 
cells within (a) passage 0 and (b) passage 1 ADC and BMDC 
cultures. Percentage positivity was analysed within the total cell 
population. Non-viable cells were excluded using propidium 
iodide staining. Data were analysed using Student’s t-test.
*p < 0.05, n = 5.
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CD90+ cells than BMDC cultures (ADCs: 91% CD29+, 
57% CD90+ and 51% CD29+/CD90+; BMDCs: 64% 
CD29+, 36% CD90+ and 28% CD29+/CD90+). No signifi-
cant (p < 0.05) differences were identified between ADCs 
and BMDCs at P1 (ADCs: 98% CD29+, 73% CD90+ and 
66% CD29+/CD90+; BMDCs: 99% CD29+, 84% CD90+ 
and 78% CD29+/CD90+).
Sort recovery and cell viability in FACS buffer
The influence of time spent by isolated cells in FACS 
buffer on cell viability was determined. Data demonstrated 
that ADCs and BMDCs stored in FACS buffer for up to 
60 min (Figure 2(a)) displayed >90% viability. ADCs 
showed >90% viability over the total 270-min incubation, 
while BMDCs only showed >90% viability for up to 
150 min. Following 270 min in FACS buffer, cell viability 
decreased by 8% for ADCs and 23% for bone marrow stro-
mal cells (BMSCs) when compared with time point 0. 
Significant (p < 0.05) differences in cell viability were 
observed between ADCs and BMDCs at time points of 
120, 180 and 210 min.
The number of viable cells retrieved after FACS (sort 
recovery) was determined using Trypan blue cell counts, 
which were performed immediately after cell selection. 
ADCs (84%) demonstrated a significantly (p < 0.05) 
higher sort recovery when compared with BMDCs (69%) 
(Figure 2(b)).
Differentiation
Osteogenic differentiation was analysed using AR staining 
and quantification. AR staining indicated that calcium 
deposition was significantly (p < 0.05) reduced in CD29+/
CD90+ cultures when compared with unsorted and unla-
belled controls (Figure 3(1)). Significant (p < 0.05) differ-
ences in AR staining were observed between the CD29+/
CD90+ and the unlabelled controls (i.e. cells processed 
through the FACS instrument but lacking primary anti-
body) in both ADC and BMDC cultures. A significant 
(p < 0.05) reduction in AR staining was also observed 
when unlabelled cells were compared with unsorted cells.
Adipogenic differentiation was analysed using ORO 
staining and quantification. CD29+/CD90+ ADCs and 
BMDCs showed significantly (p < 0.05) reduced intracellular 
lipid formation, as assessed by ORO staining and quantifica-
tion, when compared with unsorted controls (Figure 3(2)). 
No statistically significant (p < 0.05) differences in ORO 
staining were identified between the CD29+/CD90+ and the 
unlabelled controls in ADC and BMDC cultures. A signifi-
cant (p < 0.05) reduction in ORO staining was observed 
when unlabelled cells were compared with unsorted cells.
Gene expression analysis for stem cell markers
To further analyse the effects of enrichment for CD29+/
CD90+ on stem cell phenotype, cells sorted using these 
surface markers were compared with unsorted controls. 
Semi-quantitative reverse-transcription polymerase chain 
reaction (sqRT-PCR) analysis demonstrated that CD29+/
CD90+ selection significantly reduced (p < 0.05) expres-
sion levels of pluripotent marker genes (Nanog, Lin28 and 
Sox2) within primary ADC cultures, but had no significant 
(p < 0.05) effect on the expression of these genes in BMDC 
cultures (Figure 4(a)). CD29+/CD90+ BMDCs showed a 
significantly (p < 0.05) higher expression of Lin28, Nanog 
and Sox2 compared with CD29+/CD90+ ADCs. Expression 
of CD29 and CD90 was significantly (p < 0.05) increased 
Figure 2. (a) Viability of ADCs and BMDCs maintained in FACS buffer (sterile PBS + 1% FBS) over a period of 270 min. Cell 
viability counts were performed using Trypan blue staining at 30-min intervals and (b) sort recovery of ADCs and BMDCs following 
FACS, as determined by Trypan blue staining.
*p < 0.05, n = 5.
 at UNIV OF BIRMINGHAM on July 10, 2015tej.sagepub.comDownloaded from 
6 Journal of Tissue Engineering 
in CD29+/CD90+ ADCs and BMDCs, supporting the valid-
ity of the FACS process. The expression of CD73 within 
the adipose fraction was significantly (p < 0.05) decreased 
following CD29+/CD90+ selection. CD29+/CD90+ selec-
tion had no significant (p > 0.05) effect on the expression 
of CD73 within BMDCs (Figure 4(b)). No significant 
(p > 0.05) changes were observed in CD105 expression for 
ADC and BMDC cultures following CD29+/CD90+ selec-
tion. CD29+/CD90+ BMDCs showed a significantly 
(p < 0.05) higher expression of CD29 and CD73 than 
CD29+/CD73+ ADCs. CD29+/CD90+ ADCs displayed sig-
nificantly higher expression of CD90 than BMDCs.
Discussion
Previous studies have demonstrated that CD29+/CD90+ 
expression is preserved among MSCs isolated from many 
different species,3,33 with these markers being used to iso-
late cells that have some level of osteogenic/adipogenic 
potential.10,19,21,22 However, to our knowledge, no previous 
studies have compared CD29+/CD90+ cells with TCP-
adherent controls to confirm that this selection criterion 
enhances culture responses important for tissue engineer-
ing applications. This is an important distinction, since 
adherence to TCP was the initial method of stem cell selec-
tion first identified by Friedenstein et al.,23 and regimes 
utilising ex vivo expansion with only minimal surface 
marker characterisation currently represent popular and 
easily employable methods for generating autologous cells 
for clinical transplantation.34,35 However, the immunologi-
cal consequences of such procedures are still subject to 
intensive research.35
In this study, we identified that selection of CD29+/
CD90+ cells within BMDC cultures caused no significant 
Figure 3. Osteogenic and adipogenic differentiation analysed by (1) alizarin red (AR) and (2) Oil Red-O (ORO) staining, 
respectively. AR staining and quantification were used to identify calcium deposition. ORO staining and quantification were used 
to identify lipid accumulation. For both assays, CD29+/CD90+, unlabelled and unsorted (a) ADC and (b) BMDC cultures were 
compared. Both analyses were performed following a 21-day culture in osteogenic or adipogenic medium.
*p < 0.05, n = 3.
 at UNIV OF BIRMINGHAM on July 10, 2015tej.sagepub.comDownloaded from 
Davies et al. 7
(p < 0.05) changes in any of the stem cell markers analysed. 
Moreover, CD29+/CD90+ ADC populations showed signifi-
cantly (p < 0.05) lower levels of expression of several pluri-
potent marker genes (Lin28, Sox2 and Nanog) when 
compared with unsorted controls. These genes represent 
members of a panel of pluripotent factors required for stem 
cell self-renewal and maintenance that can be transfected, 
along with OCT4, to induce reversion to an induced pluripo-
tent state.36,37 In corroboration with these gene expression 
data, this study also demonstrated that CD29+/CD90+ 
enrichment significantly (p < 0.05) decreased the capacity of 
both ADCs and BMDCs to differentiate towards an osteo-
genic/adipogenic phenotype when compared with unsorted 
controls. We identify that these data may have implications 
when considering the role of accessory cells located within 
the adipose and bone marrow niche for stem cell function 
and differentiation, which shall be discussed below.
Previous studies have shown that MSC selection using 
TCP-adherence gives an initially heterogeneous popula-
tion of cells that becomes increasingly homogeneous as 
they are propagated on TCP.38,39 In fact, it has been shown 
that MSCs isolated using TCP-adherence reach a similar 
level of homogeneity to those isolated using flow cytom-
etry after three passages.37 This study identified that in 
the case of CD29+/CD90+ cells, achieving homogeneity 
using TCP-selection is at faster rate for BMDCs than for 
ADCs. This may be due to the persistent presence of 
more committed colony-forming CD29+/CD90− adipo-
cyte progenitors within ADC cultures.20,40 At passage 1, 
CD29+/CD90+ ADCs and BMDCs make up 66% and 
78% of the total cell population, respectively. Therefore, 
unsorted passage 1 cells used in this study should be 
identified as a largely heterogeneous population, rather 
than a pure MSC population. However, previous studies 
Figure 4. Gene expression analysis comparing levels of transcripts associated with stem cell: (a) pluripotency and (b) multipotency 
for CD29+/CD90+ ADCs and BMDCs isolated using FACS, with unsorted controls. All analyses were performed on passage 1 cells 
that had reached ~80% confluence.
*p < 0.05, n = 3.
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have shown that such heterogeneity may be of benefit, 
with many reports highlighting the importance of main-
taining the stem cell niche for optimal MSC function.41,42 
Furthermore, the use of explant cultures within tissue 
engineering studies highlights the importance of main-
taining features of the stem cell niche in vitro.43,44 This is 
due to multifaceted effect that the stem cell niche has 
been shown to have in coordinating and controlling the 
participation of MSCs in tissue maintenance, repair and 
regeneration through the action of paracrine factors.45,46 
Therefore, exploiting or mimicking elements of the MSC 
niche in vitro is becoming increasingly important for 
improving the efficacy of current tissue engineering 
research.47,48 Findings presented in this study, together 
with our previously published data, support the hypothe-
sis that maintaining cellular heterogeneity within adipose 
and bone marrow cultures facilitates MSC differentia-
tion.25 Additionally, employing TCP-adherence rather 
than targeted cell selection for the isolation of MSCs 
increases the initial degree of heterogeneity, potentially 
reducing phenotypic changes known to occur when 
MSCs are removed from their native environment, and 
thereby facilitating a more stable ex vivo transition.49
The differentiation capacity of unlabelled cells was 
significantly increased when compared with CD29+/
CD90+ cells. However, this study identified that unla-
belled cells had a decreased capacity for differentiation 
when compared with unsorted cells. This suggests that 
cell selection at a low sort rate using a cuvette-based cell 
sorter (FACSAria II) had a small yet identifiable effect on 
MSC differentiation. Flow cytometry both profiles and 
sorts cells via the application of hydrodynamic pressure, 
which is used to align the cells into single droplets that 
can be accurately analysed. However, previous studies 
have indicated that changes in gene expression can result 
from nuclear distortions occurring from the application of 
pressure to cells, with MSCs being particularly suscepti-
ble due to the presence of large nuclei and relatively mini-
mal cytoplasm.50–52 Additionally, mechanical stimulation 
has been found to influence the expression of pluripotent 
genes such as Nanog and Sox2 through rearrangement of 
the actin cytoskeleton.53,54 In light of this information, it 
could be hypothesised that hydrodynamic forces encoun-
tered during FACS may cause distortions in cell and/or 
nuclear shape, and that these changes may be associated 
with alterations in gene expression and differentiation, 
which were observed for ADCs and BMDCs in this study. 
In light of this information, it becomes necessary to fur-
ther define the benefits or drawbacks of using a cuvette-
based flow cytometer when isolating cells for tissue 
engineering applications. We identify that further studies 
will need to be conducted in order to compare the effects 
of cuvette-based flow cytometry, highlighted in this study, 
with the alternative ‘jet-in-air’ approaches. Finally, we 
suggest that immunomagnetic cell sorting may represent a 
comparatively sensitive approach when compared with 
the cuvette-based FACS system. As such, this approach 
may represent more appropriate methods of cell selection 
if isolating MSCs for downstream applications.55,56
In addition to hydrodynamic stresses encountered dur-
ing FACS, antibody labelling, blocking, washing and 
transportation, which precede the FACS process, require 
the storage of cells in a low-serum FACS buffer, which 
we hypothesised may have a negative effect on cell via-
bility. In this study, cell viability was assessed over a 
270-min period to investigate differences in protocol, as 
well as differences in possible transport times, which 
would be useful for those that do not have a FACS instru-
ment located on site. Our data indicated site-specific dif-
ferences in the ability of CD29+/CD90+ cells isolated 
from two different sources to survive during maintenance 
in FACS buffer and following FACS, with ADCs seem-
ingly representing a more robust cell type than BMDCs. 
Data supporting the comparative robustness of stem/pro-
genitor cells derived from adipose tissue are corroborated 
by a previous study showing that ADCs maintain their 
phenotype with age and increasing time spent in cul-
ture.57 The ability of ADCs to survive out of culture for 
longer periods than BMDCs and survive hydrodynamic 
stresses encountered during FACS may also be related to 
the discovery of a population of multi-lineage differenti-
ating stress-enduring (Muse) cells within adipose tis-
sue.58 These cells are able to endure extreme stresses 
such as hypoxia, serum deprivation, long-term exposure 
to proteolytic enzymes such as collagenase and low tem-
peratures.59,60 Similar cell populations with the ability to 
survive extreme stress have not yet been identified within 
bone marrow.
To conclude, this study showed that CD29+/CD90+ 
cells isolated from rat adipose and bone marrow tissues 
demonstrated a reduced differentiation capacity when 
compared with MSCs isolated using TCP-adherence. As a 
result of this study, we identify that CD29+/CD90+ pre-
sorting may not be the most appropriate selection criterion 
for the isolation of multipotent cells from rats. We also 
identify that maintaining heterogeneity within MSC cul-
tures may be of benefit for improved differentiation. We 
acknowledge that further characterisation of rat MSCs will 
be required if they are to provide accurate and translatable 
tissue engineering models that can be used in pre-clinical 
studies. Finally, our findings also have implications for the 
use of cuvette-based flow cytometry for MSC isolation for 
translational tissue regeneration applications. Given the 
prevalence of this method of flow cytometry for the isola-
tion of MSCs preceding tissue engineering, further studies 
into the effects of hydrodynamic forces experienced dur-
ing cell sorting on cellular function are of importance.
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